Abstract
Background The close relationships between mental disorders and suicidality are frequently seen in epidemiology. Shared genetic liabilities and brain structure variation may underlie these associations. Therefore, we aimed to investigate the phenotypic and polygenetic associations between multiple mental disorders and different levels of suicidality, as well as mediation by grey morphology and white matter tracts.
Methods Using raw data from the UK Biobank (UKB) European population, we first evaluated the phenotypic and polygenic relationships between 12 mental disorders and gradient scales of suicidality. We then accessed data from the All of Us (AoU) diverse cohort to replicate findings in European and African American populations. Demographic and social factors, including age, sex, BMI, education, deprivation, income, smoking, and chronic pain were included as covariates. Second, we used existing genome-wide association study (GWAS) summary statistics from 12 major mental conditions to estimate genetic correlations and identify pleiotropic genes using a combination of statistical genetics tools. Third, we further explored the potential mediation effects of brain structure on the relationship between mental disorders and suicidality through structural equation modeling and Mendelian randomization analyses.
Results In the UKB European population, 150,861 eligible individuals were retained after standard GWAS quality control. Nine out of 12 mental disorders showed both significant phenotypic and polygenic correlations with gradient suicidality (Pbonferroni <0.05). Using GWAS summary statistics, we also observed positive global and regional genetic correlations between the 12 mental disorders and suicidality (rg ranging from 0.25 to 0.68, Pbonferroni <0.05). Across pairs of suicidality and other mental disorders, we identified 73 out of 136 pleiotropic functional genes (including 58 novel ones associated with suicidality) shared by two or more pairs. These genes were enriched in pathways including regulation of immune system process and DNA, nucleosome and chromatin organization, and phenotypes as common mental disorders and brain morphology. Finally, the association between mental disorders and suicidality was significantly mediated by several structural brain imaging features.
Conclusion This study underscores the urgent need to address the shared and distinct genetic architecture of suicidality and its related mental conditions. Combining longitudinal population-level biobanks with disease-ascertained GWAS data is warranted to further enhance our understanding of this complex phenomenon. Our research findings will guide future suicide prevention and precise treatment among individuals with or without major mental disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was financially supported by the National Nature Science Foundation of China (Grant NO. 82171499 to QW, and Grant NO. 82301683 to ST), Chinese National Programs for Brain Science and Brian-like Intelligence Technology, China Depression Cohort Study (STI2030-Major Projects-2021ZD0200700 to QW), Science and Technology Project of Sichuan Province (Grant NO. 2023YFS0030 to QW), Natural Science Foundation of Sichuan Province (Grant no. 2024NSFSC1560 to ST). HG is supported by Mentored Scientist Grant in Henry Ford Health (A20067), NIH grant R03MH135347, and American Foundation for Suicide Prevention grant SRG-0-061-23.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board (IRB) of Henry Ford Health gave ethical approval for this work(project No. 16896-01).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.